CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers

Rochelle A. Simon, P. Anthony di Sant'Agnese, Li Shan Huang, Haodong Xu, Jorge L. Yao, Qi Yang, Sharon Liang, Jinsong Liu, Rena Yu, Liang Cheng, William K. Oh, Ganesh S. Palapattu, Jianjun Wei, Jiaoti Huang

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Small cell neuroendocrine carcinoma of the prostate is a rare variant of prostatic cancer that shares morphologic similarity with prostatic adenocarcinoma of Gleason 5 pattern. It has also been considered morphologically and immunohistochemically indistinguishable from small cell neuroendocrine carcinomas of other origins. CD44 is a cell-surface molecule proposed to identify cancer stem/progenitor cells in prostate cancer. We performed immunohistochemical study for CD44 expression in 11 cases of prostatic small cell neuroendocrine carcinoma and compared its patterns of expression with 73 cases of prostatic adenocarcinoma and 47 cases of small cell neuroendocrine carcinomas of other organs. Strong and diffuse membrane staining for CD44 was observed in 100% of the prostatic small cell neuroendocrine carcinomas. In conventional adenocarcinomas of the prostate, positive staining was only seen in rare, scattered tumor cells; and CD44 staining was negative in most of the small cell neuroendocrine carcinomas of nonprostate origin. The difference in CD44 expression between small cell neuroendocrine carcinomas of the prostate and those of other organs are statistically significant (P < .001). Our study demonstrates the utility of immunohistochemical staining for CD44 in distinguishing prostatic small cell neuroendocrine carcinoma from its mimickers including prostatic adenocarcinoma of Gleason 5 pattern and small cell neuroendocrine carcinomas of other organs. CD44 is the first marker that shows a high degree of tissue/organ specificity for small cell neuroendocrine carcinomas. Because CD44 is a putative marker of prostate cancer stem cells, the strong and diffuse expression of CD44 and the lack of expression of prostate luminal differentiation markers androgen receptor and prostatic specific antigen in prostatic small cell neuroendocrine carcinomas suggest that the tumor cells may retain cancer stem cell features.

Original languageEnglish
Pages (from-to)252-258
Number of pages7
JournalHuman Pathology
Volume40
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Neuroendocrine Carcinoma
Small Cell Carcinoma
Neoplastic Stem Cells
Prostate
Adenocarcinoma
Prostatic Neoplasms
Organ Specificity
Staining and Labeling
Negative Staining
Differentiation Antigens
Androgen Receptors
Neoplasms
Stem Cells

Keywords

  • Adenocarcinoma
  • CD44
  • Immunohistochemistry
  • Prostate
  • Small cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Simon, R. A., di Sant'Agnese, P. A., Huang, L. S., Xu, H., Yao, J. L., Yang, Q., ... Huang, J. (2009). CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. Human Pathology, 40(2), 252-258. https://doi.org/10.1016/j.humpath.2008.07.014

CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. / Simon, Rochelle A.; di Sant'Agnese, P. Anthony; Huang, Li Shan; Xu, Haodong; Yao, Jorge L.; Yang, Qi; Liang, Sharon; Liu, Jinsong; Yu, Rena; Cheng, Liang; Oh, William K.; Palapattu, Ganesh S.; Wei, Jianjun; Huang, Jiaoti.

In: Human Pathology, Vol. 40, No. 2, 02.2009, p. 252-258.

Research output: Contribution to journalArticle

Simon, RA, di Sant'Agnese, PA, Huang, LS, Xu, H, Yao, JL, Yang, Q, Liang, S, Liu, J, Yu, R, Cheng, L, Oh, WK, Palapattu, GS, Wei, J & Huang, J 2009, 'CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers', Human Pathology, vol. 40, no. 2, pp. 252-258. https://doi.org/10.1016/j.humpath.2008.07.014
Simon, Rochelle A. ; di Sant'Agnese, P. Anthony ; Huang, Li Shan ; Xu, Haodong ; Yao, Jorge L. ; Yang, Qi ; Liang, Sharon ; Liu, Jinsong ; Yu, Rena ; Cheng, Liang ; Oh, William K. ; Palapattu, Ganesh S. ; Wei, Jianjun ; Huang, Jiaoti. / CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. In: Human Pathology. 2009 ; Vol. 40, No. 2. pp. 252-258.
@article{1636aeaec7004d5fb93705e9e654ad3e,
title = "CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers",
abstract = "Small cell neuroendocrine carcinoma of the prostate is a rare variant of prostatic cancer that shares morphologic similarity with prostatic adenocarcinoma of Gleason 5 pattern. It has also been considered morphologically and immunohistochemically indistinguishable from small cell neuroendocrine carcinomas of other origins. CD44 is a cell-surface molecule proposed to identify cancer stem/progenitor cells in prostate cancer. We performed immunohistochemical study for CD44 expression in 11 cases of prostatic small cell neuroendocrine carcinoma and compared its patterns of expression with 73 cases of prostatic adenocarcinoma and 47 cases of small cell neuroendocrine carcinomas of other organs. Strong and diffuse membrane staining for CD44 was observed in 100{\%} of the prostatic small cell neuroendocrine carcinomas. In conventional adenocarcinomas of the prostate, positive staining was only seen in rare, scattered tumor cells; and CD44 staining was negative in most of the small cell neuroendocrine carcinomas of nonprostate origin. The difference in CD44 expression between small cell neuroendocrine carcinomas of the prostate and those of other organs are statistically significant (P < .001). Our study demonstrates the utility of immunohistochemical staining for CD44 in distinguishing prostatic small cell neuroendocrine carcinoma from its mimickers including prostatic adenocarcinoma of Gleason 5 pattern and small cell neuroendocrine carcinomas of other organs. CD44 is the first marker that shows a high degree of tissue/organ specificity for small cell neuroendocrine carcinomas. Because CD44 is a putative marker of prostate cancer stem cells, the strong and diffuse expression of CD44 and the lack of expression of prostate luminal differentiation markers androgen receptor and prostatic specific antigen in prostatic small cell neuroendocrine carcinomas suggest that the tumor cells may retain cancer stem cell features.",
keywords = "Adenocarcinoma, CD44, Immunohistochemistry, Prostate, Small cell carcinoma",
author = "Simon, {Rochelle A.} and {di Sant'Agnese}, {P. Anthony} and Huang, {Li Shan} and Haodong Xu and Yao, {Jorge L.} and Qi Yang and Sharon Liang and Jinsong Liu and Rena Yu and Liang Cheng and Oh, {William K.} and Palapattu, {Ganesh S.} and Jianjun Wei and Jiaoti Huang",
year = "2009",
month = "2",
doi = "10.1016/j.humpath.2008.07.014",
language = "English",
volume = "40",
pages = "252--258",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers

AU - Simon, Rochelle A.

AU - di Sant'Agnese, P. Anthony

AU - Huang, Li Shan

AU - Xu, Haodong

AU - Yao, Jorge L.

AU - Yang, Qi

AU - Liang, Sharon

AU - Liu, Jinsong

AU - Yu, Rena

AU - Cheng, Liang

AU - Oh, William K.

AU - Palapattu, Ganesh S.

AU - Wei, Jianjun

AU - Huang, Jiaoti

PY - 2009/2

Y1 - 2009/2

N2 - Small cell neuroendocrine carcinoma of the prostate is a rare variant of prostatic cancer that shares morphologic similarity with prostatic adenocarcinoma of Gleason 5 pattern. It has also been considered morphologically and immunohistochemically indistinguishable from small cell neuroendocrine carcinomas of other origins. CD44 is a cell-surface molecule proposed to identify cancer stem/progenitor cells in prostate cancer. We performed immunohistochemical study for CD44 expression in 11 cases of prostatic small cell neuroendocrine carcinoma and compared its patterns of expression with 73 cases of prostatic adenocarcinoma and 47 cases of small cell neuroendocrine carcinomas of other organs. Strong and diffuse membrane staining for CD44 was observed in 100% of the prostatic small cell neuroendocrine carcinomas. In conventional adenocarcinomas of the prostate, positive staining was only seen in rare, scattered tumor cells; and CD44 staining was negative in most of the small cell neuroendocrine carcinomas of nonprostate origin. The difference in CD44 expression between small cell neuroendocrine carcinomas of the prostate and those of other organs are statistically significant (P < .001). Our study demonstrates the utility of immunohistochemical staining for CD44 in distinguishing prostatic small cell neuroendocrine carcinoma from its mimickers including prostatic adenocarcinoma of Gleason 5 pattern and small cell neuroendocrine carcinomas of other organs. CD44 is the first marker that shows a high degree of tissue/organ specificity for small cell neuroendocrine carcinomas. Because CD44 is a putative marker of prostate cancer stem cells, the strong and diffuse expression of CD44 and the lack of expression of prostate luminal differentiation markers androgen receptor and prostatic specific antigen in prostatic small cell neuroendocrine carcinomas suggest that the tumor cells may retain cancer stem cell features.

AB - Small cell neuroendocrine carcinoma of the prostate is a rare variant of prostatic cancer that shares morphologic similarity with prostatic adenocarcinoma of Gleason 5 pattern. It has also been considered morphologically and immunohistochemically indistinguishable from small cell neuroendocrine carcinomas of other origins. CD44 is a cell-surface molecule proposed to identify cancer stem/progenitor cells in prostate cancer. We performed immunohistochemical study for CD44 expression in 11 cases of prostatic small cell neuroendocrine carcinoma and compared its patterns of expression with 73 cases of prostatic adenocarcinoma and 47 cases of small cell neuroendocrine carcinomas of other organs. Strong and diffuse membrane staining for CD44 was observed in 100% of the prostatic small cell neuroendocrine carcinomas. In conventional adenocarcinomas of the prostate, positive staining was only seen in rare, scattered tumor cells; and CD44 staining was negative in most of the small cell neuroendocrine carcinomas of nonprostate origin. The difference in CD44 expression between small cell neuroendocrine carcinomas of the prostate and those of other organs are statistically significant (P < .001). Our study demonstrates the utility of immunohistochemical staining for CD44 in distinguishing prostatic small cell neuroendocrine carcinoma from its mimickers including prostatic adenocarcinoma of Gleason 5 pattern and small cell neuroendocrine carcinomas of other organs. CD44 is the first marker that shows a high degree of tissue/organ specificity for small cell neuroendocrine carcinomas. Because CD44 is a putative marker of prostate cancer stem cells, the strong and diffuse expression of CD44 and the lack of expression of prostate luminal differentiation markers androgen receptor and prostatic specific antigen in prostatic small cell neuroendocrine carcinomas suggest that the tumor cells may retain cancer stem cell features.

KW - Adenocarcinoma

KW - CD44

KW - Immunohistochemistry

KW - Prostate

KW - Small cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=58149116823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149116823&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2008.07.014

DO - 10.1016/j.humpath.2008.07.014

M3 - Article

C2 - 18835619

AN - SCOPUS:58149116823

VL - 40

SP - 252

EP - 258

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 2

ER -